Literature DB >> 15624751

Treatment of Nevus comedonicus with topical tazarotene and calcipotriene.

Steven B Deliduka1, Pearl C Kwong.   

Abstract

Nevus comedonicus is a rare developmental defect of the pilosebaceous unit. It is also thought to be a variant of epidermal nevus. Previously reported treatments include surgical excision, CO2 laser, dermabrasion, extraction, topical retinoic acid, and numerous topical keratolytics. We present a case of a 7-year-old boy with bilateral nevus comedonicus who experienced cosmetic improvement with topical tazarotene and calcipotriene cream. This combination represents a novel therapeutic approach to the treatment of this cutaneous abnormality.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15624751

Source DB:  PubMed          Journal:  J Drugs Dermatol        ISSN: 1545-9616            Impact factor:   2.114


  5 in total

1.  Inflammatory nevus comedonicus with epidermoid cyst.

Authors:  Namrata Chhabra; Deepika Pandhi; Prashant Verma; Sonal Sharma
Journal:  Indian J Dermatol       Date:  2014-07       Impact factor: 1.494

2.  Nevus comedonicus: an updated review.

Authors:  Georgi Tchernev; Julian Ananiev; Kristina Semkova; Lyubomir A Dourmishev; Jaqueline Schönlebe; Uwe Wollina
Journal:  Dermatol Ther (Heidelb)       Date:  2013-05-25

3.  Bowenoid papulosis of the genitalia successfully treated with topical tazarotene: a report of two cases.

Authors:  Veeranna Shastry; Jayadev Betkerur
Journal:  Indian J Dermatol       Date:  2009-07       Impact factor: 1.494

4.  Extensive Nevus Comedonicus with Inflammatory Nodules and Cysts Controlled with Adalimumab.

Authors:  Eun Hye Lee; Seon Hwa Lee; Chihyeon Sohng; Jun Young Kim; Kyung Duck Park; Seok-Jong Lee; Weon Ju Lee
Journal:  Ann Dermatol       Date:  2021-07-01       Impact factor: 1.444

5.  Dermoscopy on nevus comedonicus: a case report and review of the literature.

Authors:  Grażyna Kamińska-Winciorek; Radosław Spiewak
Journal:  Postepy Dermatol Alergol       Date:  2013-08-27       Impact factor: 1.837

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.